Science, our reliance on the foundations of epidemiology, and management of a public health crisis have been unprecedented discussion topics this year. We have never had a greater need to rely on data, science, and the evolving understanding of experts about the COVID-19 coronavirus and how to contend with it.
Each year more than 50,000 stem cell transplantations are completed worldwide. The stimulation, harvesting, and therapeutic use of patient and donor cells has evolved as a treatment for diverse cancer diagnoses, and specially trained nurses are at the heart of the clinical trials and care delivery to propel cell transplant therapy across practice settings.
Until recently, past ONS President Deborah Mayer, PhD, RN, AOCN®, FAAN, served as interim director of the National Cancer Institute’s (NCI’s) Office of Cancer Survivorship, a part of the Division of Cancer Control and Population Sciences. As an oncology nurse, Mayer brought a special perspective to the office’s mission to better understand and meet the unique needs of the growing number of U.S. cancer survivors.
During a global pandemic that requires social distancing, telehealth has suddenly become routine. Seeing an opportunity, the Centers for Medicare and Medicaid Services (CMS) is breaking down barriers, enhancing patient-centered care, and bolstering the healthcare workforce with a series of regulations, with telehealth topping the list.
Approximately 700 members responded to ONS’s 2020 genomics survey, which gauged oncology nurses’ current genomic knowledge, applications in practice, and the specific questions they have about genetics and genomics. Here are the answers to the most frequently asked questions based on the survey responses.
As families follow public health recommendations to stay at home, many have missed routine vaccinations. In response to lower vaccination rates, the U.S. Department of Health and Human Services (HHS) released an amendment to the Public Readiness and Emergency Preparedness Act to encourage vaccinations and safeguard children at risk for life-threatening diseases.
Cancer treatment often causes symptoms that result in treatment delays and unplanned care, which adversely affects patient outcomes, healthcare costs, and patient satisfaction. To decrease those possibilities, the ONS Center for Innovation launched ONS On-Call™, an oncology-specific decision support tool to guide standardized, evidence-based symptom assessment and leverage ONS’s proprietary evidence-based resources for patient-reported symptoms.
Patients throughout the United States still face persistent inequities across the healthcare continuum because of social determinants of health and inequity in research, Shannon N. Zenk, PhD, MPH, RN, FAAN, director of the National Institute of Nursing Research (NINR) recognized.
Does lack of inclusion in areas that are important to us affect how we see ourselves overall? Can someone amplify their voice without being represented in an authority position? Should leadership reflect the population that it’s leading? More and more medical organizations are publishing formal and informal position statements on diversity and inclusion, which is a great start, but the next logical step is bringing those beliefs and concepts to our institutions and communities. Here are some of the issues and the ways that any nurse can take action.
Cervical cancer rates have dropped more than 90% among women who received the human papillomavirus (HPV) vaccine, according to the results of a Swedish study published in the New England Journal of Medicine. Global health leaders are calling it a milestone study.